201 related articles for article (PubMed ID: 25082450)
1. Depigmentation caused by application of the active brightening material, rhododendrol, is related to tyrosinase activity at a certain threshold.
Kasamatsu S; Hachiya A; Nakamura S; Yasuda Y; Fujimori T; Takano K; Moriwaki S; Hase T; Suzuki T; Matsunaga K
J Dermatol Sci; 2014 Oct; 76(1):16-24. PubMed ID: 25082450
[TBL] [Abstract][Full Text] [Related]
2. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism.
Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S
Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809
[TBL] [Abstract][Full Text] [Related]
3. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
[TBL] [Abstract][Full Text] [Related]
4. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
[TBL] [Abstract][Full Text] [Related]
5. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.
Abe Y; Okamura K; Kawaguchi M; Hozumi Y; Aoki H; Kunisada T; Ito S; Wakamatsu K; Matsunaga K; Suzuki T
J Dermatol Sci; 2016 Jan; 81(1):35-43. PubMed ID: 26547111
[TBL] [Abstract][Full Text] [Related]
6. Tyrosinase-catalyzed oxidation of rhododendrol produces 2-methylchromane-6,7-dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity.
Ito S; Ojika M; Yamashita T; Wakamatsu K
Pigment Cell Melanoma Res; 2014 Sep; 27(5):744-53. PubMed ID: 24903082
[TBL] [Abstract][Full Text] [Related]
7. Glutathione maintenance is crucial for survival of melanocytes after exposure to rhododendrol.
Kondo M; Kawabata K; Sato K; Yamaguchi S; Hachiya A; Takahashi Y; Inoue S
Pigment Cell Melanoma Res; 2016 Sep; 29(5):541-9. PubMed ID: 27223685
[TBL] [Abstract][Full Text] [Related]
8. [Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss].
Nishimaki-Mogami T
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2015; (133):13-20. PubMed ID: 26821466
[TBL] [Abstract][Full Text] [Related]
9. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects.
Solano F; Briganti S; Picardo M; Ghanem G
Pigment Cell Res; 2006 Dec; 19(6):550-71. PubMed ID: 17083484
[TBL] [Abstract][Full Text] [Related]
10. Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma.
Yoshikawa M; Sumikawa Y; Hida T; Kamiya T; Kase K; Ishii-Osai Y; Kato J; Kan Y; Kamiya S; Sato Y; Yamashita T
J Dermatol; 2017 May; 44(5):582-587. PubMed ID: 27882588
[TBL] [Abstract][Full Text] [Related]
11. Tyrosinase-catalyzed metabolism of rhododendrol (RD) in B16 melanoma cells: production of RD-pheomelanin and covalent binding with thiol proteins.
Ito S; Okura M; Nakanishi Y; Ojika M; Wakamatsu K; Yamashita T
Pigment Cell Melanoma Res; 2015 May; 28(3):295-306. PubMed ID: 25713930
[TBL] [Abstract][Full Text] [Related]
12. Copper chelation by d-penicillamine alleviates melanocyte death induced by rhododendrol without inhibiting tyrosinase.
Nagatani K; Abe Y; Homma T; Fujii J; Suzuki T
Biochem Biophys Res Commun; 2023 Jun; 663():71-77. PubMed ID: 37119768
[TBL] [Abstract][Full Text] [Related]
13. 4-(4-Hydroxyphenyl)-2-butanol (rhododendrol)-induced melanocyte cytotoxicity is enhanced by UVB exposure through generation of oxidative stress.
Goto N; Tsujimoto M; Nagai H; Masaki T; Ito S; Wakamatsu K; Nishigori C
Exp Dermatol; 2018 Jul; 27(7):754-762. PubMed ID: 29630780
[TBL] [Abstract][Full Text] [Related]
14. Biochemical Mechanism of Rhododendrol-Induced Leukoderma.
Ito S; Wakamatsu K
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439519
[No Abstract] [Full Text] [Related]
15. Upregulation of CD86 and IL-12 by rhododendrol in THP-1 cells cocultured with melanocytes through ROS and ATP.
Katahira Y; Sakamoto E; Watanabe A; Furusaka Y; Inoue S; Hasegawa H; Mizoguchi I; Yo K; Yamaji F; Toyoda A; Yoshimoto T
J Dermatol Sci; 2022 Dec; 108(3):167-177. PubMed ID: 36610941
[TBL] [Abstract][Full Text] [Related]
16. Human tyrosinase is able to oxidize both enantiomers of rhododendrol.
Ito S; Gerwat W; Kolbe L; Yamashita T; Ojika M; Wakamatsu K
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1149-53. PubMed ID: 25130058
[TBL] [Abstract][Full Text] [Related]
17. Depigmentation effect of kadsuralignan F on melan-a murine melanocytes and human skin equivalents.
Goh MJ; Lee HK; Cheng L; Kong DY; Yeon JH; He QQ; Cho JC; Na YJ
Int J Mol Sci; 2013 Jan; 14(1):1655-66. PubMed ID: 23322017
[TBL] [Abstract][Full Text] [Related]
18. Depigmentation of melanocytes by the treatment of extracts from traditional Chinese herbs: a cell culture assay.
Zhong S; Wu Y; Soo-Mi A; Zhao J; Wang K; Yang S; Jae-Ho Y; Zhu X
Biol Pharm Bull; 2006 Sep; 29(9):1947-51. PubMed ID: 16946515
[TBL] [Abstract][Full Text] [Related]
19. The effect of rhododendrol inhibition of NF-κB on melanocytes in the presence of tyrosinase.
Arase N; Yang L; Tanemura A; Yang F; Suenaga T; Arase H; Katayama I
J Dermatol Sci; 2016 Aug; 83(2):157-9. PubMed ID: 27174091
[No Abstract] [Full Text] [Related]
20. Inhibition of melanin content by Punicalagins in the super fruit pomegranate (Punica granatum).
Rana J; Diwakar G; Saito L; Scholten JD; Mulder T
J Cosmet Sci; 2013; 64(6):445-53. PubMed ID: 24397882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
